Iowa Admin. Code r. 657-7.10

Current through Register Vol. 47, No. 8, October 30, 2024

Rule 657-7.10 - Ensuring rational drug therapy

An important aspect of pharmaceutical services is that of maximizing rational drug use. Policies and procedures for ensuring the quality of drug therapy shall be established pursuant to rule 657-8.3 (155A). For the purpose of this rule, "professional pharmacy staff means the professional employees of the pharmacy, including pharmacists, pharmacy technicians, and pharmacist-interns.

(1)Patient profile. The pharmacy shall maintain for each patient receiving care at the hospital a patient profile, to include but not be limited to drug history. Sufficient patient information to ensure meaningful and effective patient care shall be collected, maintained, and reviewed by professional pharmacy staff pursuant to policies and procedures. Appropriate clinical information about patients shall be available and accessible to the pharmacist for use in daily practice. Upon review of a patient's current clinical profile, the pharmacist shall directly communicate any suggested changes to the patient's health care team.

(2)Adverse drug events. Established policies and procedures shall include a mechanism for the reporting of adverse drug events that occur in the facility which events are reviewed by the facility's established quality control committee. The pharmacist shall be informed of all reported adverse drug events occurring in the facility. Adverse drug events include but are not limited to adverse drug reactions and medication errors.

Iowa Admin. Code r. 657-7.10

Amended by IAB April 15, 2015/Volume XXXVII, Number 21, effective 5/20/2015

Amended by IAB January 30, 2019/Volume XLI, Number 16, effective 3/6/2019